Pier Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Pier Capital’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-231,162	Closed	-$5.62M	–	129
2023 Q1	$5.62M	Buy	231,162 +2,410	+1%	+$52.8K	0.85%	65
2022 Q4	$4.9M	Sell	228,752 -3,230	-1%	-$68.9K	0.8%	63
2022 Q3	$4.16M	Sell	231,982 -110,905	-32%	-$1.46M	0.72%	72
2022 Q2	$3.3M	Sell	342,887 -213,954	-38%	-$2.69M	0.56%	79
2022 Q1	$9.37M	Buy	556,841 +128,387	+30%	+$1.9M	1.2%	32
2021 Q4	$7.16M	Buy	+428,454	New	+$7.02M	0.76%	73
2016 Q3	–	Sell	-110,679	Closed	-$5.65M	–	141
2016 Q2	$5.65M	Buy	+110,679	New	+$5.5M	1.03%	37
2014 Q1	–	Sell	-107,355	Closed	-$3.47M	–	163
2013 Q4	$3.47M	Buy	+107,355	New	+$3.19M	0.46%	94

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Pier Capital's ISEE Position: Q2 2023 in Review

Pier Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 231,162 shares — an estimated $5.62M sold.

Pier Capital first reported a position in ISEE in Q4 2013 and held it in 8 quarters. The position peaked at $9.37M in Q1 2022. 255 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

Pier Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Pier Capital sold 231,162 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $5.62M.
Pier Capital first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 8 quarters.
Pier Capital's IVERIC bio, Inc. Common Stock position peaked at $9.37M in Q1 2022.
255 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Pier Capital's 13F filing for Q2 2023, filed 14 Aug 2023.